evans blue has been researched along with Alloxan Diabetes in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (13.89) | 18.7374 |
| 1990's | 8 (22.22) | 18.2507 |
| 2000's | 15 (41.67) | 29.6817 |
| 2010's | 8 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, X; Gao, Y; Li, J; Liu, R; Xu, Y; Ye, C; Zhang, Y | 1 |
| Ballmer Hofer, K; Bates, DO; Beazley-Long, N; Bestall, SM; Donaldson, LF; Harper, SJ; Hulse, RP; Riaz, H; Singhal, P; Ved, N | 1 |
| Chen, X; Gao, S; Jacobson, O; Kiesewetter, DO; Lang, L; Liu, Y; Ma, Q; Ma, Y; Wang, G; Zhang, H; Zhu, L | 1 |
| Li, CP; Liu, B; Liu, XM; Song, SG; Wang, WQ | 1 |
| Cetin, A; Demir, T; Demirkazik, A; Dökmetas, HS; Gulturk, S; Kosar, I | 1 |
| Arnold, E; Clapp, C; Colosi, P; Díaz-Lezama, N; Jeziorski, MC; Martínez de la Escalera, G; Moreno-Carranza, B; Ramírez, M; Wu, Z | 1 |
| Karolczak, K; Labieniec-Watala, M; Rozalska, S; Watala, C; Wieczorek, M | 1 |
| Chen, J; Chopp, M; Cui, X; Lu, M; Ning, R; Roberts, C; Yan, T; Zacharek, A; Zhang, C | 1 |
| Arican, N; Elmas, I; Kalayci, R; Kaya, M; Korkut, F; Küçük, M; Kudat, H | 1 |
| Dosso, AA; Rungger-Brändle, E | 1 |
| Kalkan, T; Oztaş, B; Tuncel, H | 1 |
| Battistini, B; Gabra, BH; Lawson, SR; Nantel, F; Sirois, P | 1 |
| Chang, YH; Chen, CH; Chen, JT; Chen, PL; Lu, DW; Tai, MC | 1 |
| Houser, KA; Huber, JD; VanGilder, RL | 1 |
| Awad, AS | 1 |
| Clarke, KG; Gil, DW; Kusari, J; Padillo, E; Zhou, S | 1 |
| Almulki, L; Frimmel, S; Gragoudas, ES; Hafezi-Moghadam, A; Kim, IK; Miller, JW; Nakazawa, T; Noda, K; Skondra, D; Tayyari, F; Thomas, KL; Zandi, S | 1 |
| Dai, W; Ji, F; Jin, Y; Li, W; Lu, L; Luo, Y; Sinclair, SH; Wu, Y; Xu, G; Xu, GT; Yanoff, M; Zhang, J | 1 |
| Abdouh, M; Couture, R; Hasséssian, HM; Talbot, S | 1 |
| Küçük, M; Oztaş, B | 1 |
| Murakami, K; Uezu, Y | 1 |
| Ender, F; Fazekas, A; Fehér, E; Györfi, A; Rosivall, L | 1 |
| Cao, Z; Cooper, ME; Hulthén, UL; Johnston, CI; Rumble, JR | 1 |
| Chakir, M; Ettaouil, K; Lehoux, S; Plante, GE; Sirois, P | 1 |
| Chakir, M; Plante, GE | 1 |
| Caspers-Velu, LE; Kador, PF; Rapoport, SI; Wadhwani, KC | 1 |
| Farkas, B; Németh, J; Oroszi, G; Peitl, B; Sári, R; Szilvássy, Z; Szolcsányi, J; Thán, M | 1 |
| Sitniewska, EM; Wiśniewska, RJ | 1 |
| Adamis, AP; Qaum, T; Xu, Q | 1 |
| Gotloib, L; Shostak, A; Wajsbrot, V | 1 |
| Adamis, AP; Clemens, MW; Hassessian, H; Joussen, AM; Miyamoto, K; Qaum, T; Qin, W; Rudge, J; Wiegand, SJ; Xu, Q; Yancopoulos, GD | 1 |
| Hallmans, G; Lithner, F | 1 |
| Jakobsen, J; Malmgren, L; Olsson, Y | 1 |
| Hägg, E; Hallmans, G; Lithner, F | 1 |
| Amemiya, K; Kimura, M; Suzuki, J; Yamada, T | 1 |
| Camurcu, S; Oztaş, B | 1 |
1 review(s) available for evans blue and Alloxan Diabetes
| Article | Year |
|---|---|
Consequences of alteration in capillary permeability.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin Receptor Antagonists; Capillary Permeability; Cardiomyopathies; Diabetes Mellitus, Experimental; Eicosanoids; Endothelium, Vascular; Evans Blue; Extracellular Matrix; Hydrostatic Pressure; Hypertension; Microcirculation | 1996 |
35 other study(ies) available for evans blue and Alloxan Diabetes
| Article | Year |
|---|---|
Ultrasound-mediated microbubble destruction increases renal interstitial capillary permeability in early diabetic nephropathy rats.
Topics: Animals; Blotting, Western; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Evans Blue; Male; Microbubbles; Microscopy, Confocal; Microscopy, Electron; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Ultrasonic Therapy; Ultrasonography; Urinalysis | 2014 |
Vascular endothelial growth factor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration.
Topics: Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Evaluation, Preclinical; Evans Blue; Female; Ganglia, Spinal; Hyperglycemia; Male; Nerve Degeneration; Neuralgia; Rats, Sprague-Dawley; Rats, Wistar; Sensory Receptor Cells; TRPA1 Cation Channel; TRPC Cation Channels; Vascular Endothelial Growth Factor A | 2015 |
Stable Evans Blue Derived Exendin-4 Peptide for Type 2 Diabetes Treatment.
Topics: Animals; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Stability; Evans Blue; Exenatide; Humans; Hypoglycemic Agents; Maleimides; Mice, Inbred C57BL; Naphthalenesulfonates; Peptides; Serum Albumin; Venoms | 2016 |
Lignans Extracted from Eucommia Ulmoides Oliv. Protects Against AGEs-Induced Retinal Endothelial Cell Injury.
Topics: Animals; Blood-Retinal Barrier; Cell Line; Cell Survival; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Eucommiaceae; Evans Blue; Gene Expression Regulation; Glycation End Products, Advanced; Heme Oxygenase-1; Hyperglycemia; Lignans; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Plant Extracts; Plant Leaves; Reactive Oxygen Species; Retina; Signal Transduction; Streptozocin | 2016 |
Effect of exposure to 50 Hz magnetic field with or without insulin on blood-brain barrier permeability in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Blood-Brain Barrier; Diabetes Mellitus, Experimental; Electromagnetic Fields; Evans Blue; Insulin; Rats; Rats, Wistar; Streptozocin | 2010 |
Vasoinhibin gene transfer by adenoassociated virus type 2 protects against VEGF- and diabetes-induced retinal vasopermeability.
Topics: Albumins; Animals; Capillary Permeability; Cell Cycle Proteins; Coloring Agents; Dependovirus; Dextrans; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Evans Blue; Fluorescein-5-isothiocyanate; Gene Transfer Techniques; Genetic Therapy; Green Fluorescent Proteins; HEK293 Cells; Humans; Intravitreal Injections; Male; Plasmids; Rats; Rats, Wistar; Retinal Hemorrhage; Vascular Endothelial Growth Factor A | 2011 |
Poly(amido)amine dendrimers generation 4.0 (PAMAM G4) reduce blood hyperglycaemia and restore impaired blood-brain barrier permeability in streptozotocin diabetes in rats.
Topics: Animals; Blood Glucose; Brain; Coumaric Acids; Dendrimers; Dextrans; Diabetes Mellitus, Experimental; Evans Blue; Fluorescein; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Hyperglycemia; Monocarboxylic Acid Transporters; Nylons; Permeability; Rats; Rats, Sprague-Dawley; Symporters | 2012 |
Tissue plasminogen activator treatment of stroke in type-1 diabetes rats.
Topics: Animals; Blood-Brain Barrier; Blotting, Western; Cerebral Hemorrhage; Coloring Agents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Evans Blue; Fibrinolytic Agents; Immunohistochemistry; Infarction, Middle Cerebral Artery; Male; Matrix Metalloproteinase 9; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Recovery of Function; Stroke; Tissue Plasminogen Activator; Toll-Like Receptor 4; Treatment Outcome | 2012 |
Effect of losartan on the blood-brain barrier permeability in diabetic hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Blood-Brain Barrier; Diabetes Mellitus, Experimental; Epinephrine; Evans Blue; Hypertension; Losartan; Male; NG-Nitroarginine Methyl Ester; Permeability; Rats; Rats, Wistar | 2003 |
Streptozotocin-induced diabetes--a rat model to study involvement of retinal cell types in the onset of diabetic retinopathy.
Topics: Animals; Capillary Permeability; Coloring Agents; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Evans Blue; Glycogen; Neurotransmitter Agents; Rats; Rats, Long-Evans; Retina; Retinal Vessels | 2003 |
Influence of 50 Hz frequency sinusoidal magnetic field on the blood-brain barrier permeability of diabetic rats.
Topics: Animals; Blood Glucose; Blood-Brain Barrier; Brain; Cerebellum; Coloring Agents; Diabetes Mellitus, Experimental; Electromagnetic Fields; Evans Blue; Magnetic Resonance Imaging; Magnetics; Male; Permeability; Rats; Rats, Wistar; Streptozocin | 2004 |
Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic profile of major key organs.
Topics: Animals; Blood Glucose; Bradykinin; Bradykinin B1 Receptor Antagonists; Capillary Permeability; Cardiomyopathies; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Diabetic Retinopathy; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Insulin; Male; Rats; Rats, Wistar; Receptor, Bradykinin B1; Renal Insufficiency; Time Factors; Tissue Distribution; Triglycerides; Vascular Diseases | 2005 |
Hyperbaric oxygen therapy ameliorates the blood-retinal barrier breakdown in diabetic retinopathy.
Topics: Animals; Blood-Retinal Barrier; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Evans Blue; Fluorescein-5-isothiocyanate; Hyperbaric Oxygenation; Male; Microscopy, Fluorescence; Rats; Rats, Sprague-Dawley; Retinal Vessels; Serum Albumin, Bovine | 2006 |
Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats.
Topics: Animals; Blood-Brain Barrier; Brain; Capillary Permeability; Carbon Radioisotopes; Central Nervous System; Cognition Disorders; Coloring Agents; Diabetes Mellitus, Experimental; Disease Models, Animal; Endothelium, Vascular; Evans Blue; Hypoglycemic Agents; Insulin; Male; Microcirculation; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sucrose; Tight Junctions; Tritium | 2006 |
Role of AT1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Blood-Brain Barrier; Body Weight; Brain; Capillary Permeability; Diabetes Mellitus, Experimental; Epinephrine; Evans Blue; Glutathione; Hypertension; Indicators and Reagents; Lipid Peroxidation; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Superoxide Dismutase; Tetrazoles; Time Factors | 2006 |
Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Blood-Retinal Barrier; Body Weight; Cell Count; Coloring Agents; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Electroretinography; Evans Blue; Excitatory Amino Acid Antagonists; Male; Memantine; Optic Nerve Diseases; Rats; Rats, Inbred BN; Retina; Retinal Ganglion Cells; Retinal Vessels; Streptozocin; Vascular Endothelial Growth Factor A; Vitreous Body | 2007 |
Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
Topics: Animals; Antimicrobial Cationic Peptides; Aprotinin; Blood Proteins; Blood-Retinal Barrier; Capillary Permeability; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Evans Blue; Male; Monocyte Chemoattractant Proteins; Rats; Rats, Inbred BN; Rats, Long-Evans; Retinal Vessels; Serine Proteinase Inhibitors; Vascular Endothelial Growth Factor A | 2008 |
Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.
Topics: Animals; Apoptosis; Blood-Retinal Barrier; Blotting, Western; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Erythropoietin; Evans Blue; Immunoenzyme Techniques; In Situ Nick-End Labeling; Injections; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Erythropoietin; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; STAT5 Transcription Factor; Vitreous Body | 2008 |
Retinal plasma extravasation in streptozotocin-diabetic rats mediated by kinin B(1) and B(2) receptors.
Topics: Acetylcysteine; Animals; Antioxidants; Benzothiazoles; Blood-Retinal Barrier; Bradykinin; Diabetes Mellitus, Experimental; Diamines; Dose-Response Relationship, Drug; Edema; Evans Blue; Male; Organic Chemicals; Oxidative Stress; Plasma; Quinolines; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Retina; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2008 |
Influence of acute arterial hypertension on blood-brain barrier permeability in streptozocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Blood Pressure; Blood-Brain Barrier; Diabetes Mellitus, Experimental; Epinephrine; Evans Blue; Hypertension; Male; Permeability; Rats; Rats, Wistar | 1995 |
A possible mechanism for increased cerebrovascular permeability in diabetic rats: effects of insulin and 2-deoxy-glucose.
Topics: Animals; Blood Glucose; Capillary Permeability; Cerebrovascular Circulation; Deoxyglucose; Diabetes Mellitus, Experimental; Evans Blue; Insulin; Male; Rats; Rats, Wistar | 1993 |
Effects of streptozotocin-induced diabetes on neurogenic inflammation of gingivomucosal tissue in rat.
Topics: Administration, Topical; Animals; Capillary Permeability; Capsaicin; Coloring Agents; Diabetes Mellitus, Experimental; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Gingiva; Gingivitis; Irritants; Ligation; Male; Microscopy, Electron; Mouth Mucosa; Nerve Fibers; Neurons, Afferent; Nociceptors; Rats; Rats, Wistar; Stomatitis; Streptozocin; Stress, Mechanical | 1996 |
Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
Topics: Analysis of Variance; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Capillary Permeability; Cardiomegaly; Coloring Agents; Coronary Vessels; Diabetes Mellitus, Experimental; Dihydropyridines; Evans Blue; Hypertension; Hypertrophy; Kidney; Male; Mesenteric Arteries; Ramipril; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Serum Albumin; Tetrazoles; Valine; Valsartan | 1996 |
Endothelial dysfunction in diabetes mellitus.
Topics: Aldehyde Reductase; Animals; Capillary Permeability; Coloring Agents; Diabetes Mellitus, Experimental; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Evans Blue; Female; Guanidines; Imidazoles; Imidazolidines; Nitric Oxide; Rats; Rats, Sprague-Dawley; Serum Albumin; Sorbitol | 1996 |
Iris vasculopathy in galactose-fed rats.
Topics: Aldehyde Reductase; Animals; Blood Vessels; Blood-Aqueous Barrier; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Enzyme Inhibitors; Evans Blue; Female; Fluorenes; Galactose; Horseradish Peroxidase; Hydantoins; Iris; Microscopy, Electron; Permeability; Rats; Rats, Sprague-Dawley | 1999 |
Impairment of neurogenic inflammatory and anti-inflammatory responses in diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Electric Stimulation; Evans Blue; Fasting; Inflammation; Insulin; Male; Neural Conduction; Rats; Rats, Wistar; Sciatic Nerve; Somatostatin | 1999 |
Influence of secretin and L-NAME on vascular permeability in the coronary circulation of intact and diabetic rats.
Topics: Animals; Capillary Permeability; Coronary Circulation; Diabetes Mellitus, Experimental; Drug Interactions; Evans Blue; Heart Atria; Heart Ventricles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Secretin; Ventricular Function | 2001 |
Sensitive blood-retinal barrier breakdown quantitation using Evans blue.
Topics: Animals; Blood-Retinal Barrier; Capillary Leak Syndrome; Capillary Permeability; Coloring Agents; Diabetes Mellitus, Experimental; Endothelial Growth Factors; Evans Blue; Lymphokines; Male; Organ Size; Rats; Rats, Sprague-Dawley; Retinal Vessels; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Protective effect of aminoguanidine upon capillary and submesothelial anionic sites.
Topics: Albuminuria; Animals; Anions; Basement Membrane; Capillary Permeability; Diabetes Mellitus, Experimental; Endothelium, Vascular; Epithelium; Evans Blue; Guanidines; Male; Microscopy, Electron; Peritoneal Dialysis; Peritoneum; Rats; Rats, Sprague-Dawley; Serum Albumin | 2001 |
VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Topics: Animals; Blood-Retinal Barrier; Capillary Permeability; Coloring Agents; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Growth Factors; Evans Blue; Lymphokines; Male; Rats; Rats, Sprague-Dawley; Retinal Vessels; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Cutaneous reactions to local traumatization with heat in alloxan diabetic rabbits with and without ketosis.
Topics: Animals; Blood Glucose; Body Water; Burns; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Ketoacidosis; Evans Blue; Rabbits; Skin | 1978 |
Permeability of the blood-nerve barrier in the streptozotocin-diabetic rat.
Topics: Animals; Blood; Cytochrome c Group; Diabetes Mellitus, Experimental; Evans Blue; Horseradish Peroxidase; Male; Permeability; Rats; Sciatic Nerve; Serum Albumin, Bovine | 1978 |
Early cutaneous reactions to local traumatization with heat in alloxan diabetic rats.
Topics: Alkaline Phosphatase; Animals; Body Water; Burns; Diabetes Mellitus, Experimental; Evans Blue; Male; Rats; Rats, Inbred Strains; Skin | 1978 |
Quantitative method for measuring adjuvant-induced granuloma angiogenesis in insulin-treated diabetic mice.
Topics: Angiography; Animals; Carmine; Diabetes Mellitus, Experimental; Evans Blue; Freund's Adjuvant; Granuloma; Insulin; Male; Mice; Mice, Inbred ICR; Neovascularization, Pathologic | 1986 |
Blood-brain barrier permeability after electrically induced seizure in normoglycemic, hypoglycemic, and hyperglycemic rats.
Topics: Animals; Blood Pressure; Blood-Brain Barrier; Capillary Permeability; Diabetes Mellitus, Experimental; Electric Stimulation; Endothelium, Vascular; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Hyperglycemia; Hypoglycemia; Male; Rats; Rats, Inbred Strains; Seizures | 1989 |